| Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update MK Arora, UK Singh Vascular pharmacology 58 (4), 259-271, 2013 | 313 | 2013 |
| Discovery, development, and patent trends on molnupiravir: a prospective oral treatment for COVID-19 M Imran, M Kumar Arora, SMB Asdaq, SA Khan, SI Alaqel, ... Molecules 26 (19), 5795, 2021 | 185 | 2021 |
| Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism P Balakumar, MK Arora, J Reddy, MB Anand-Srivastava Journal of cardiovascular pharmacology 54 (2), 129-138, 2009 | 119 | 2009 |
| Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions P Balakumar, MK Arora, SS Ganti, J Reddy, M Singh Pharmacological Research 60 (1), 24-32, 2009 | 119 | 2009 |
| Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy M Kumar Arora, U Kumar Singh Current drug targets 15 (5), 531-538, 2014 | 112 | 2014 |
| The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy MK Arora, K Reddy, P Balakumar European journal of pharmacology 636 (1-3), 137-144, 2010 | 73 | 2010 |
| Emerging role of PPAR ligands in the management of diabetic nephropathy P Balakumar, MK Arora, M Singh Pharmacological research 60 (3), 170-173, 2009 | 59 | 2009 |
| Amelioration of Diabetes-Induced Diabetic Nephropathy by Aloe vera: Implication of Oxidative Stress and Hyperlipidemia MK Arora, Y Sarup, R Tomar, M Singh, P Kumar Journal of dietary supplements 16 (2), 227-244, 2019 | 43 | 2019 |
| The multifaceted role of mangiferin in health and diseases: a review. A Jangra, MK Arora, A Kisku, S Sharma Advances in Traditional Medicine 21, 619–643, 2020 | 27 | 2020 |
| Combined therapy with ivermectin and doxycycline can effectively alleviate the cytokine storm of COVID-19 infection amid vaccination drive: A narrative review SK Sharma, P Bhatt, SMB Asdaq, MK Alshammari, A Alanazi, ... Journal of Infection and Public Health 15 (5), 566-572, 2022 | 22 | 2022 |
| MmpL3 inhibition as a promising approach to develop novel therapies against tuberculosis: a spotlight on SQ109, clinical studies, and patents literature M Imran, MK Arora, A Chaudhary, SA Khan, M Kamal, MM Alshammari, ... Biomedicines 10 (11), 2793, 2022 | 12 | 2022 |
| Therapeutic potential of policosanol in the concurrent management of dyslipidemia and non-alcoholic fatty liver disease MK Arora, S Pandey, R Tomar, J Sahoo, D Kumar, A Jangra Future Journal of Pharmaceutical Sciences 8 (1), 11, 2022 | 11 | 2022 |
| Insight into the biological impact of COVID-19 and its vaccines on human health VD Ashwlayan, C Antlash, M Imran, SMB Asdaq, MK Alshammari, ... Saudi Journal of Biological Sciences, 2022 | 11 | 2022 |
| Neuroprotective and acetylcholinesterase inhibitory activity of plumbagin in ICV-LPS induced behavioral deficits in rats A Jangra, V Chadha, D Kumar, V Kumar, MK Arora Current Research in Behavioral Sciences 2, 100060, 2021 | 11 | 2021 |
| Hypoxia induced lactate acidosis modulates tumor microenvironment and lipid reprogramming to sustain the cancer cell survival L Singh, L Nair, D Kumar, MK Arora, S Bajaj, MM Gadewar, SS Mishra, ... Frontiers in Oncology 13, 69, 2023 | 10 | 2023 |
| Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects M Imran, MK Alshammari, MK Arora, AK Dubey, SS Das, M Kamal, ... biomedicines 11, 278, 2023 | 9 | 2023 |
| Mangiferin ameliorates intracerebroventricular-quinolinic acid-induced cognitive deficits, oxidative stress, and neuroinflammation in Wistar rats MK Arora, A Kisku, A Jangra Indian Journal of Pharmacology 52 (4), 296-305, 2020 | 8 | 2020 |
| Morphological effect of combination of fenofibrate and saxagliptin on kidney of diabetic rats MK Arora, UK Singh, R Bansal Int J Pharmcy Pharm Sci 6 (4), 483-487, 2014 | 7 | 2014 |
| Plumbagin Alleviates Intracerebroventricular-Quinolinic Acid Induced Depression-like Behavior and Memory Deficits in Wistar Rats MK Arora, A Ratra, SMB Asdaq, AA Alshamrani, AJ Alsalman, M Kamal, ... Molecules 27 (6), 1834, 2022 | 6 | 2022 |
| Neuroprotective Efficacy of Edaravone against Arsenic-Induced Behavioral and Neurochemical Deficits in Rats: Amelioration of Cholinergic and Mitochondrial Functions MK Arora, D Singh, R Tomar, A Jangra CNS & neurological disorders drug targets 22 (1), 125–136, 2023 | 5 | 2023 |
